Standing Committee Member, Young and Middle-Aged Experts Committee, National Stroke Prevention and Control Program, National Health Commission
National Outstanding Young and Middle-Aged Expert for Stroke Screening and Prevention, National Health Commission
Deputy Director, Tianjin Neurology Quality Control Center
Standing Committee Member, Neurology Branch, Tianjin Medical Association
Vice President, Neurology Branch, Tianjin Medical Doctor Association
Council Member, Tianjin Society for Neuroscience
Dissertation Review Expert, Academic Degrees Center, Ministry of Education
Review Expert, Shanghai Municipal Science and Technology Commission
Doctoral Supervisor Evaluation Expert, Fujian Medical University
Professional Title Review Expert, Fujian Medical University
Professional Title Evaluation Expert, Anhui Medical University
Review Expert for Provincial Science and Technology Programs, Hebei
Review Expert for Provincial Science and Technology Programs, Heilongjiang
Editorial Board Member, Chinese Journal of Comprehensive Clinical Medicine
Dr. Zhang specializes in cerebrovascular diseases, with a core focus on acute ischemic stroke and intravenous thrombolytic therapy. She possesses rich experience in emergency stroke care, reperfusion therapy, standardized stroke management, secondary prevention and the development and implementation of stroke quality-control systems.
She has long been dedicated to improving the standardization, accessibility and quality of intravenous thrombolysis for acute ischemic stroke. Over a 14-year period, Dr. Zhang led Ward IV, Department of Neurology, Tianjin Huanhu Hospital, delivering intravenous thrombolytic therapy to over 18,600 patients with acute ischemic stroke, with a peak of 179 cases per month and 13 cases in a single day.
Under her leadership, the team built an exceptionally high single-center intravenous thrombolysis caseload and ranked first nationwide in the comprehensive assessment of intravenous thrombolysis among Advanced Stroke Centers for 10 consecutive years. These achievements have contributed substantially to the implementation and promotion of standardized intravenous thrombolytic therapy for acute ischemic stroke in China.
From 2013 to 2022, Dr. Zhang chaired the Intravenous Thrombolysis Forum at the China Stroke Conference for 10 consecutive years. She has also delivered standardized training on intravenous thrombolytic therapy for acute ischemic stroke to more than 3,000 neurologists across China.
Dr. Zhang is a recipient of the Special Government Allowance granted by the State Council and has been recognized as a National Health Science Popularization Expert. She has also served as a Council Member of the Chinese Medical Doctor Association, Vice President of the Tianjin Medical Doctor Association, and Visiting Professor at Stanford University in the United States.
Her major honors include the 2020 UNESCO International Lifetime Achievement Award for Stroke Prevention and Management, National Advanced Individual in the Healthcare System (2017), Outstanding Member of the Communist Party of China, Tianjin (2018), and Tianjin May-1st Labor Medal (2019). In 2020, she was recognized as one of the inaugural recipients of the title “Tianjin Distinguished Physician”. In 2022, she was selected as “China’s Good Doctor” (May) and was named a Tianjin March 8th Red-Banner Pacesetter.
Dr. Zhang has made remarkable contributions to clinical research on cerebrovascular diseases and published over 60 academic papers in domestic and international journals, including 21 SCI-indexed papers as first or corresponding author.
Working together with 13 base hospitals of the National Health Commission’s Stroke Prevention and Control Program, including Peking Union Medical College Hospital, Nanjing Drum Tower Hospital and Xuanwu Hospital, Capital Medical University, she took part in a multicenter study investigating intravenous thrombolysis and endovascular therapy rates for acute ischemic stroke in China from 2019 to 2020. The study was published online in February 2022 in a journal affiliated with The Lancet.
Dr. Zhang also helped develop professional training materials and served as an editor for the Training Manual on Clinical Diagnosis and Treatment Techniques for Stroke. She has also co-authored several professional neurological monographs, further advancing professional education and the roll-out of standardized stroke care.